The ongoing Ebola outbreak in the Democratic Republic of Congo has claimed the lives of nearly 100 children, and the number of cases are on the rise.
Patient completed required 21-day monitoring period and did not develop any symptoms.
So far, the American has not shown any symptoms of infection from the virus.
The immunogenicity generated by 3 experimental Ebola vaccines appears to be long-lasting, as it has persisted for at least 2.5 years.
A simple intradermalanti-Ebola DNA vaccine may generate strong immunogenicity and induce long-term immune responses in nonhuman primates.
Ebola infections in newborns are being reported in the current outbreak of the deadly disease in Congo.
The current Ebola outbreak in Congo is the worst in the country’s recorded history.
A fast, single-use fingerstick test for infection with the Ebola virus has been approved by the FDA.
It may not be possible to bring the Ebola outbreak in Congo under control, and the deadly disease may become entrenched in the northeastern part of the country.
The latest Ebola outbreak in Congo is not yet severe enough to be declared a global emergency.
WHO reports two cases of the deadly virus were confirmed near the border with Uganda.
Two of the first 10 people to receive an experimental Ebola treatment have recovered from the highly dangerous disease.
Four more experimental treatments for Ebola virus have been approved by the Congo health ministry for use in an outbreak of the deadly infectious disease in the country’s northeast.
First to be vaccinated will be health workers, contacts of confirmed Ebola patients
The number of confirmed cases in a new Ebola outbreak in Congo has reached 13, including three deaths.
Just a week after being declared Ebola-free, the DRC said that a new outbreak of the deadly virus has killed at least 20 people.
Outbreak report describes transmission of Ebola virus one year after survival of Ebola virus disease.
The latest Ebola outbreak in the Democratic Republic of Congo is over according to the WHO.
Survivors of Ebola virus disease have localized pathological changes in photoreceptors.
Study provides new data on the durability of the humoral immune response up to 2 years after single-dose injection with rVSV-ZEBOV vaccine in a population of primarily European ancestry, and additional data on durability at 1 year after vaccination in 2 African populations.